Skip to content

US · SNYR · MEDICAL - DISTRIBUTION

Synergy CHC Corp. (SNYR) intrinsic value and stock valuation

$0.09as of 2026-11-21 · Mkt cap 1.76M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Synergy CHC Corp. DCF and intrinsic value

InvestorsCraft values SNYR with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from SNYR’s statements →

Synergy CHC Corp. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Distribution Westbrook, ME 04092 synergychc.com

How the business is doing

Fiscal 2012–2025, USD

Revenue
$30.4M+0.7% 5y CAGRd
20122025
Net income
-$-12.34M
20122025
Free cash flow
-$-2.59M
20122025
Total equity
-$-23.13M
20122025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2012–2025, USD
20252024202320222020
Revenue$30.4M$34.8M$42.8M$38.4M$40.2M
Operating income-$-1.8M$5.8M$10.8M-$-24.97M$3.09M
Net income-$-12.34M$2.12M$6.34M-$-32.63M$1.41M
EPSd-$-1.27M$277.9K$70.5K-$-363K$15.7K
Operating cash flow-$-2.59M-$-4.8M$420K-$-8.43M-$-1.59M
Capital expenditure$0.00$0.00$0.00-$0.00-$0.00
Free cash flow-$-2.59M-$-4.8M$420K-$-8.43M-$-1.59M
Total assets$10.2M$16.3M$12.2M$18.5M$12.6M
Total debt$26.8M$27.5M$27.6M$22.8M$8.75M
Net debt$24.2M$26.8M$27M$20.9M$7.08M
Total equity-$-23.13M-$-16.63M-$-27.31M-$-33.52M-$-3.68M
Cash and short-term investments$2.62M$690K$630K$1.93M$1.67M
Income statement
20252024202320222020
Revenue$30.4M$34.8M$42.8M$38.4M$40.2M
Cost of revenue$10.1M$11.2M$10.7M$25.5M$14.7M
Gross profit$20.3M$23.6M$32.1M$13M$25.6M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$22M$17.7M$21.2M$37.9M$22.5M
Other expenses$130K$130K$30K$0.00$0.00
Operating expenses$22.1M$17.8M$21.3M$37.9M$22.5M
Cost and expenses$32.2M$29M$32M$63.4M$37.1M
Interest income$20K$0.00$0.00$0.00$0.00
Interest expense$5.92M$4.11M$4.24M$6.45M$1.3M
Depreciation and amortization$130K$130K$30K$340K$100K
Ebitda-$-6.17M$6.47M$10.8M-$-25.81M$2.81M
Operating income-$-1.8M$5.8M$10.8M-$-24.97M$3.09M
Total other income/expenses, net-$-10.43M-$-3.57M-$-4.23M-$-7.63M-$-1.67M
Income before tax-$-12.22M$2.23M$6.57M-$-32.6M$1.41M
Income tax expense$120K$100K$230K$30K$0.00
Net income-$-12.34M$2.12M$6.34M-$-32.63M$1.41M
Weighted average shares outstanding$9.72M$7.59M$7.37M$89.9M$89.9M
Weighted average diluted shares outstanding$9.72M$7.63M$89.9M$89.9M$89.9M
Balance sheet
20252024202320222020
Cash and short-term investments$2.62M$690K$630K$1.93M$1.67M
Net receivables$3.2M$11.7M$6.57M$7.91M$6.22M
Inventory$3.74M$1.72M$3.73M$7.97M$3.83M
Total current assets$10M$16.1M$11.8M$18.5M$12.6M
Property, plant and equipment, net$0.00$0.00$0.00$0.00$0.00
Goodwill and intangible assets$150K$280K$420K$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$150K$280K$420K$0.00$0.00
Total assets$10.2M$16.3M$12.2M$18.5M$12.6M
Accounts payable$0.00$0.00$0.00$110K$20K
Short-term debt$1.76M$11.7M$2.09M$1.03M$7.52M
Deferred revenue$0.00$20K$10K$0.00$120K
Total current liabilities$8.24M$17.2M$14M$30.3M$14.7M
Long-term debt$25.1M$15.8M$25.5M$21.8M$1.23M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$25.1M$15.8M$25.5M$21.8M$1.53M
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$33.3M$33M$39.6M$52.1M$16.3M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-56.44M-$-44.1M-$-46.22M-$-52.69M-$-22.82M
Accumulated other comprehensive income (loss)-$-150K-$-50K-$-100K$20K-$-10K
Total equity-$-23.13M-$-16.63M-$-27.31M-$-33.52M-$-3.68M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$26.8M$27.5M$27.6M$22.8M$8.75M
Net debt$24.2M$26.8M$27M$20.9M$7.08M
Cash flow statement
20252024202320222020
Net income-$-12.34M$2.12M$6.34M-$-32.63M$1.41M
Depreciation and amortization$1.63M$130K$30K$340K$100K
Stock-based compensation$140K$0.00$0.00$0.00$0.00
Change in working capital$1.46M-$-6.87M-$-1.62M$6.6M-$-4.44M
Accounts receivable$1.86M-$-4.62M$1.34M$1.42M-$-4.38M
Inventory-$-2.92M$1.88M$3.99M-$-7.46M-$-2.13M
Accounts payable$1.11M-$-2.81M-$-6.49M$2.86M$2.71M
Net cash provided by operating activities-$-2.59M-$-4.8M$420K-$-8.43M-$-1.59M
Investments in property, plant and equipment$0.00$0.00$0.00$0.00$0.00
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities$0.00$0.00$0.00$0.00$0.00
Common stock issued$3.72M$8.4M$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$4.65M$4.8M-$-2.09M$8.96M$1.95M
Net change in cash$1.93M$60K-$-1.79M$860K$340K
Cash at end of period$2.72M$790K$730K$2.53M$1.67M
Operating cash flow-$-2.59M-$-4.8M$420K-$-8.43M-$-1.59M
Capital expenditure$0.00$0.00$0.00-$0.00-$0.00
Free cash flow-$-2.59M-$-4.8M$420K-$-8.43M-$-1.59M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Synergy CHC Corp.

        Synergy CHC Corp. operates as a distributor of diverse consumer health, beauty, and lifestyle merchandise across the United States, Canada, and the United Kingdom. The company's brand portfolio features FOCUSfactor, specializing in nutritional supplements aimed at enhancing brain function. It also offers the Flat Tummy line, which includes a range of wellness and fashion items such as specialty teas, meal replacement shakes, lollipops, dietary aids, apparel, and exercise accessories. Furthermore, under the Hand MD brand, Synergy CHC Corp. provides anti-aging skincare products, encompassing serums and creams designed for exfoliation, skin repair, and rehydration, as well as hand hygiene products like soaps and sanitizers. These goods are made available to consumers through conventional retail partners and significant television advertising campaigns. The company's skincare range, in particular, is also sold directly via online platforms. Founded in 2010, the firm was originally named Synergy Strips Corp. and rebranded to Synergy CHC Corp. in August 2015. Its primary business operations are based in Westbrook, Maine.

        CEO
        Jack Ross
        Employees
        28
        Beta
        0.74

        Explore

        Frequently asked questions

        What is the intrinsic value of Synergy CHC Corp. (SNYR)?

        InvestorsCraft does not currently publish an intrinsic value for SNYR. How the IC value is calculated.

        Is SNYR undervalued?

        InvestorsCraft does not publish an undervaluation signal for SNYR at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.